Q4 / FY 2022

Adjusted EBITDA at 10-year
high driven by strong H1.

Pricing holding up well
throughout the year,
compensating cost inflation;
clear volume losses in H2.

+ 23% Price increase in H1 2022.

+2.4 bn euros higher variable costs.

-9% volume decline in H2.

Specialty Additives: Another quarter of double-digit price
increases, compensating for still
elevated variable costs.

Care Solutions: Positive pricing esp. for
cosmetic solutions and active cosmetic
ingredients overcompensates lower
volumes.